GNG4 and glioblastoma: Collectively from all these results, we conclude that epigenetic silencing of GNG4 in glioblastoma, specifically the mesenchymal subtype, is essential because its expression would inhibit GBM cell migration mainly through inhibition of ERK pathway downstream to SDF1α/CXCR4-dependent signaling.